What is Kerendia?
Kerendia (finerenone) is a prescription medication used to reduce the risk of sustained decline in kidney function, kidney failure, cardiovascular death, non-fatal heart attack, and hospitalization for heart failure in certain adults with chronic kidney disease (CKD) associated with type 2 diabetes.
Kerendia belongs to a class of medications known as nonsteroidal mineralocorticoid receptor antagonists (MRAs).
It is available as an oral tablet and is used alongside appropriate diabetes and kidney disease management as directed by a healthcare provider.
Indications and Benefits of Kerendia
Kerendia is prescribed for certain adults with chronic kidney disease associated with type 2 diabetes.
It may help:
- Reduce the risk of kidney function decline
- Reduce the risk of kidney failure
- Reduce the risk of cardiovascular death
- Reduce the risk of hospitalization for heart failure
- Support management of chronic kidney disease when used as prescribed
How Kerendia Works
Kerendia works by blocking mineralocorticoid receptors that may contribute to inflammation and scarring in the kidneys and cardiovascular system. This action may help reduce the progression of chronic kidney disease and lower the risk of certain cardiovascular complications in eligible patients with type 2 diabetes.
Dosage and Administration
Dosage Forms and Strengths
Kerendia is available in tablet form with two dosage strengths: 10 mg and 20 mg. The appropriate dosage is determined by a healthcare provider based on kidney function, laboratory values, and individual treatment goals.
Recommended Dosages
The starting dose of Kerendia is determined by the patient’s estimated glomerular filtration rate (eGFR). For eGFR ?60 mL/min/1.73 m², the starting dose is 20 mg once daily, and for eGFR 25-60 mL/min/1.73 m², it’s 10 mg once daily. Kerendia is not recommended for patients with eGFR <25 mL/min/1.73 m². After four weeks, the dosage may be adjusted based on eGFR and serum potassium levels.
Administration Instructions
Kerendia can be taken with or without food. For patients who have difficulty swallowing tablets, the tablet can be crushed and mixed with water or soft foods like applesauce. This mixture should be consumed immediately and not stored for future use.
Side Effects
Common Side Effects
Common side effects of Kerendia include low blood pressure (hypotension), low levels of sodium in the blood (hyponatremia), dizziness or lightheadedness, fatigue, or headache. These side effects are generally mild and may decrease over time as the body adjusts to the medication.
Serious Side Effects and Allergic Reactions
Serious side effects include high levels of potassium in the blood (hyperkalemia), which can be life-threatening if not managed properly. Symptoms of hyperkalemia include muscle weakness, slow or irregular heartbeat, and nausea. Allergic reactions to Kerendia are rare but can occur, presenting as rash, itching, swelling, severe dizziness, or trouble breathing.
Long-term Risks
Long-term use of Kerendia may require regular monitoring due to the risk of hyperkalemia. Patients with severe kidney impairment or those taking other medications that increase potassium levels should be closely monitored. Regular blood tests to check potassium and sodium levels, as well as kidney function, are recommended throughout the treatment.
Warnings and Precautions
Risks Associated with Kerendia
While Kerendia offers significant benefits in managing chronic kidney disease associated with type 2 diabetes, it also presents certain risks that require careful management:
- Hyperkalemia (High Potassium Levels): This is the most notable risk associated with Kerendia. Hyperkalemia can lead to serious cardiac issues if not managed properly. Patients with advanced kidney disease or those taking other medications that elevate potassium levels (like ACE inhibitors, ARBs, or certain diuretics) are particularly at risk. Symptoms of hyperkalemia include muscle weakness, fatigue, and heart palpitations, and it requires immediate medical attention.
- Hypotension (Low Blood Pressure): Kerendia may cause a drop in blood pressure, particularly in patients who are dehydrated, on diuretics, or have a low blood volume. This can lead to dizziness or fainting, and it’s important for patients to be aware of these symptoms, especially when standing up quickly from a sitting or lying position.
Conditions Under Which Kerendia Should Not Be Used
Kerendia’s use is contraindicated or should be approached with caution in certain conditions:
- Severe Renal Impairment: Patients with an eGFR below 15 mL/min/1.73 m², or those with end-stage kidney disease, should not use Kerendia due to the increased risk of hyperkalemia and other complications. In such cases, the risks outweigh the potential benefits.
- Adrenal Insufficiency: In patients with adrenal insufficiency, Kerendia should be used with caution. This condition can already predispose patients to elevated potassium levels, and adding Kerendia might exacerbate this risk.
Necessary Medical Tests Before and During Treatment
To ensure safe use of Kerendia, certain medical tests are recommended:
- Serum Potassium and eGFR Levels: Before initiating treatment, it’s crucial to check serum potassium and eGFR levels. These tests help in determining whether Kerendia is safe to start and at what dosage.
- Regular Monitoring: Once on Kerendia, regular monitoring of serum potassium is essential, particularly during the first month or after any dose adjustments. This helps in early detection and management of hyperkalemia. Monitoring kidney function through eGFR is also important to assess the ongoing impact of the medication and to make any necessary adjustments in therapy.
- Patient Education: Patients should be educated about the signs and symptoms of hyperkalemia and hypotension. They should also be advised on the importance of maintaining scheduled lab tests and follow-up appointments.
While Kerendia is a valuable medication for managing CKD in type 2 diabetes, it requires careful monitoring and consideration of patient-specific factors to ensure its safe use. Regular medical tests and patient awareness are key components of its effective management.
Interactions with Other Medications
Information on Drug Interactions
Kerendia’s interactions with other medications can significantly impact its effectiveness and safety profile:
- Strong CYP3A4 Inhibitors: These include certain antifungal medications (like ketoconazole and itraconazole) and antibiotics (such as clarithromycin). When used with Kerendia, these drugs can increase the levels of finerenone in the body, potentially leading to an increased risk of side effects, most notably hyperkalemia.
- Drugs Increasing Potassium Levels: Medications such as ACE inhibitors (like lisinopril), angiotensin receptor blockers (ARBs, such as losartan), and potassium-sparing diuretics (like spironolactone) can raise potassium levels in the blood. When combined with Kerendia, there is a heightened risk of hyperkalemia, which can have serious cardiac implications.
- Other Potential Interactions: Other drugs that may interact with Kerendia include lithium (used in bipolar disorder), nonsteroidal anti-inflammatory drugs (NSAIDs), and certain blood pressure medications. These interactions can affect how Kerendia or the other medications work or increase the risk of side effects.
Special Considerations for Use with Other Medications
When Kerendia is used in conjunction with other medications, special considerations are necessary:
- Close Monitoring: Patients taking Kerendia along with other medications that can affect potassium levels or kidney function should be closely monitored. This includes regular blood tests to check potassium levels and kidney function.
- Dosage Adjustments: Depending on the patient’s response and the presence of side effects, adjustments in the dosage of Kerendia or the concomitant medications may be required. This is particularly important when starting or stopping a medication known to interact with Kerendia.
- Patient Education: Patients should be educated about the potential for drug interactions and advised to inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. They should also be aware of the signs and symptoms of hyperkalemia and other potential side effects.
- Consultation with Healthcare Providers: Before starting any new medication, including over-the-counter drugs and herbal supplements, patients should consult with their healthcare provider to assess the risk of interactions with Kerendia.
Use in Specific Populations
Considerations for Use in Children
The use of Kerendia in pediatric populations requires careful consideration due to the lack of established data:
- Lack of Clinical Data: Currently, there are no sufficient studies or clinical trials that specifically evaluate the safety and efficacy of Kerendia in children. Without this data, it’s challenging to determine how the drug might affect younger patients, whose bodies can respond differently to medications compared to adults.
- Potential Risks: Given the lack of data, there are potential unknown risks that could arise from using Kerendia in pediatric patients. These risks might include unforeseen side effects or different pharmacokinetic properties in children.
- Recommendation: Due to these uncertainties, Kerendia is not recommended for use in children. Healthcare providers typically prefer to prescribe medications that have been thoroughly studied and proven safe and effective in pediatric populations.
Considerations for Use in the Elderly
Elderly patients often require special consideration when prescribing medications like Kerendia:
- Increased Sensitivity: Older adults may be more sensitive to the effects of Kerendia. This increased sensitivity can manifest as a higher susceptibility to hypotension (low blood pressure) and changes in renal function. These effects are particularly concerning in elderly patients who may already have compromised kidney function or other age-related health issues.
- Monitoring and Dosage Adjustments: Due to these risks, it’s important for healthcare providers to closely monitor elderly patients on Kerendia. This monitoring might include regular blood pressure checks and kidney function tests. Dosage adjustments may be necessary based on the patient’s response to the medication and the presence of side effects.
- Polypharmacy Considerations: Elderly patients are often on multiple medications (polypharmacy), increasing the risk of drug interactions. Careful review of all medications is essential to avoid interactions that could enhance the side effects of Kerendia or reduce its efficacy.
- Individualized Treatment: Treatment plans for elderly patients should be individualized, taking into account their overall health, existing medical conditions, and any other medications they are taking. This personalized approach helps to ensure the safe and effective use of Kerendia in this population.
Cost & Ordering Information
Buy Kerendia Through Buy Canadian Insulin
Buy Canadian Insulin helps patients access prescription medication options through participating pharmacy partners.
Pricing may vary depending on product strength, quantity selected, supplier availability, and participating pharmacy partner pricing policies.
Some patients may find pricing through participating pharmacy partners that differs from certain U.S. retail pharmacy prices.
Available services may include:
- Pricing options based on quantity selected
- Prescription processing through participating pharmacy partners
- Shipping options available across eligible U.S. delivery locations
- Ordering support through phone, email, or live chat
- Multiple quantity options depending on prescription authorization and supplier availability
Prescription medications require review and approval by a licensed healthcare professional and pharmacist before dispensing, where applicable.
Shipping timelines may vary depending on prescription review requirements, inventory availability, destination location, and carrier services.
Have a Prescription?
Patients may explore available Kerendia prescription options through participating pharmacy partners.
Available ordering features may include:
- Pricing options based on quantity selected
- Multiple quantity options depending on prescription details
- Shipping options with tracking availability when provided by the carrier
- Customer support assistance through phone, email, or live chat
- Online and phone ordering availability
Customer Support & Business Information
For questions regarding prescription processing, product availability, shipping timelines, or account support, contact Buy Canadian Insulin customer support:
Phone: 1-888-525-1815
Fax: 1-888-234-1275
Email: info@buycanadianinsulin.com
Customer Support Hours:
- Monday-Friday: 7am – 10pm CST
- Saturday & Sunday: 9am – 5pm CST
Business Address:
Buy Canadian Insulin
1026 Manitoba Avenue, Suite 1001
Selkirk, MB R1A 4M2
Canada
About Buy Canadian Insulin Services
Buy Canadian Insulin works with participating pharmacy partners to help patients access prescription medications and related healthcare products.
Product availability, pricing, and shipping timelines may vary depending on supplier inventory, participating pharmacy partner availability, and destination location.
Some prescription orders may be fulfilled through licensed pharmacy partners located in Canada or other international fulfillment locations depending on product availability.
Orders are packaged according to pharmacy handling and shipping procedures.
Have a prescription?
Order Kerendia online today and enjoy a host of benefits, including:
Disclaimer
Buy Canadian Insulin provides educational information about medications and health conditions for informational purposes only. This content is not intended to replace professional medical advice, diagnosis, or treatment. Prescription medications require valid prescription review and processing through participating pharmacy partners. Product availability, pricing, and shipping timelines may vary. Consult your healthcare provider or pharmacist before starting, stopping, or changing any medication.
